DHT Holdings, Inc. Second Quarter 2024 Results
August 12, 2024 16:15 ET
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, August 12, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended June 30, 2024. The full report is available here and...
Enovis to Participate in Upcoming Investor Conferences
August 12, 2024 16:10 ET
|
Enovis Corporation
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Graf Global Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about August 16, 2024
August 12, 2024 16:10 ET
|
Graf Global Corp.
THE WOODLANDS, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Graf Global Corp. (NYSE American: GRAF) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of...
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results
August 12, 2024 16:05 ET
|
Perspective Therapeutics, Inc.
Completed enrollment of initial Cohort 2 patients in its VMT-α-NET and VMT01 clinical trialsOn track to advance multiple pre-IND assets into the clinic in the next 12-18 monthsMaking continued...
Archrock, Inc. Announces Tender Offer for Outstanding Notes
August 12, 2024 16:05 ET
|
Archrock
HOUSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE: AROC) (“Archrock”) announced today that its subsidiaries, Archrock Partners, L.P. and Archrock Partners Finance Corp. (together, the...
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 12, 2024 16:05 ET
|
AEON Biopharma
– Progressing plans to develop ABP-450 (prabotulinumtoxinA) injection as a biosimilar utilizing BOTOX® (onabotulinumtoxinA) as the reference product – – Scheduled to hold a biosimilar initial...
Stereotaxis Reports 2024 Second Quarter Financial Results
August 12, 2024 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
August 12, 2024 16:03 ET
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
Transaction in Own Shares
August 12, 2024 13:00 ET
|
Shell plc
Transaction in Own Shares 12 August, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 12 August 2024 it purchased the following number of Shares for cancellation. ...
Minerals Technologies Announces Participation in Seaport Research Partners Annual Summer Investor Conference
August 12, 2024 12:14 ET
|
Minerals Technologies Inc.
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) announced participation in the Seaport Research Partners Annual Summer Investor Conference on August 20th, 2024....